📰 Morphic Holding News
Page 8 - Morphic Holding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Morphic Holding. Real-time updates on events, politics, business and more.
April 30, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) – Research analysts at SVB Leerink boosted their Q2 2023 earnings estimates for shares of Morphic in a report released on Tuesday, April 25th. SVB Leerink analyst M. Kratky now anticipates that the company will post earnings of ($0.85) per share for the quarter, up from their prior […]
April 30, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) CFO Marc Schegerin sold 50,000 shares of the company’s stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $54.71, for a total transaction of $2,735,500.00. Following the completion of the sale, the chief financial officer now directly owns 24,136 shares […]
April 28, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) CFO Marc Schegerin sold 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 25th. The stock was sold at an average price of $54.71, for a total transaction of $2,735,500.00. Following the sale, the chief financial officer now directly owns 24,136 shares of […]
April 28, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) CAO Robert E. Farrell, Jr. sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 25th. The stock was sold at an average price of $54.71, for a total transaction of $547,100.00. Following the transaction, the chief accounting officer now directly owns 12,222 […]
April 28, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) President Bruce Rogers sold 30,000 shares of the business’s stock in a transaction on Tuesday, April 25th. The shares were sold at an average price of $53.40, for a total transaction of $1,602,000.00. Following the sale, the president now directly owns 117,055 shares of the company’s stock, valued […]
April 27, 2023
Shares of Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) hit a new 52-week high during trading on Tuesday after BMO Capital Markets raised their price target on the stock from $83.00 to $106.00. The company traded as high as $54.97 and last traded at $52.72, with a volume of 1898374 shares trading hands. The stock […]
April 26, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) shares saw unusually-high trading volume on Wednesday after BMO Capital Markets raised their price target on the stock from $83.00 to $106.00. Approximately 276,985 shares traded hands during trading, a decline of 37% from the previous session’s volume of 439,045 shares.The stock last traded at $49.53 and had […]
April 24, 2023
WALTHAM, Mass., April 24, 2023 -- Morphic Therapeutic , a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today... | April 24, 2023
April 21, 2023
In the first quarter of this year, total healthcare and life sciences M&A in the U.S. was about $71 billion, according to KPMG.
April 20, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) CAO Robert E. Farrell, Jr. sold 20,000 shares of the firm’s stock in a transaction dated Monday, April 17th. The shares were sold at an average price of $41.25, for a total transaction of $825,000.00. Following the sale, the chief accounting officer now owns 2,222 shares of the […]